Dimethyl Fumarate API
R&D / Scale-up Immunomodulatory Active Pharmaceutical Ingredient
📌 Product Overview
Dimethyl Fumarate is under scale-up development for immunomodulatory and multiple sclerosis trials.
✨ Key Features & Quality Advantages
- ✓Controlled particle size distribution
- ✓R&D technical data package
🔬 Applications & Formulation Uses
- 🔹Oral delayed-release capsule formulations
🏆 Why Choose PEC Pharma
- 👍Strong synthetic R&D focus
📦 Packaging & Commercial Supply
Packaged in sealed drums with desiccant protection.
📊 Technical Specifications & Quality Metrics
| PARAMETER | SPECIFICATION / RESULT |
|---|---|
| CAS Number | 624-49-7 |
| Therapeutic Category | Immunomodulators |
| Development Status | Under Scale-Up / R&D |
❓ Frequently Asked Questions (Dimethyl Fumarate API)
What is the CAS Registry Number of Dimethyl Fumarate API?
The CAS Registry Number for Dimethyl Fumarate API is 624-49-7. Synonyms include Tecfidera API, CAS 624-49-7.
Who is a reliable GMP manufacturer and supplier of Dimethyl Fumarate API in India?
PEC Pharma (PeriEleChem Pharma Pvt. Ltd.) is a leading GMP-certified manufacturer and supplier of Dimethyl Fumarate API (CAS 624-49-7) with commercial facilities in Vadodara and GIDC Saykha, Gujarat, India.
What compendial standards does Dimethyl Fumarate API meet?
Dimethyl Fumarate API API supplied by PEC Pharma complies with USP / EP Under Scale-up quality monographs. Official Certificate of Analysis (COA) PDF and regulatory documentation (DMF) support are available for commercial batches.
How can I download the Certificate of Analysis (COA) or request a bulk quote for Dimethyl Fumarate API?
You can submit a commercial quotation request form directly on this page to receive instant batch technical data, pricing, and official Certificate of Analysis (COA) from PEC Pharma.
